Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Dental School, Vita-Salute San Raffaele University and IRCCS San Raffaele Hospital, Milan, Italy.
PLoS One. 2020 Apr 24;15(4):e0228798. doi: 10.1371/journal.pone.0228798. eCollection 2020.
This study aimed to investigate salivary levels of Streptococcus mutans (S. mutans) and Lactobacilli, and other salivary indices in subjects wearing clear aligners (CA) in comparison with multibrackets orthodontic appliances (MB).
A sample of 80 participants (46 males and 34 females) was included in the study: 40 subjects (aged 20.4±1.7 years) were treated with CA, and 40 (aged 21.3±1.7 years) were treated with MB. Plaque index (PI), salivary flow, buffering power of saliva, and salivary levels of S. mutans and Lactobacilli were evaluated prior to start of orthodontic treatment (t0), after 3 months (t1) and 6 months (t2).
CA patients maintained PI at level 0 over time, while MB participants experienced a statistically significant increasing trend of PI over time. In addition, at t2, 37.5% of MB participants (15 subjects over 40) showed risky salivary levels (CFU/ml>105) of S. mutans (odds ratio = 7.40; 95% C.I. = 1.94-28.25; chi-square = 10.32; p = 0.001) as well as Lactobacilli (odds ratio = 23.40; 95% C.I. = 2.91-188.36; chi-square = 15.31; p = 0.0001).
Comparing all the data, subjects treated with CA achieved lower salivary microbial colonization after 6 months of treatment compared with MB. Different additional strategies for plaque control and salivary microbial colonization must be triggered considering the type of orthodontic appliance.
本研究旨在调查佩戴透明矫正器(CA)和多托槽矫正器(MB)的患者的变形链球菌(S. mutans)和乳杆菌的唾液水平以及其他唾液指标。
本研究纳入了 80 名参与者(46 名男性和 34 名女性):40 名患者(年龄 20.4±1.7 岁)接受 CA 治疗,40 名患者(年龄 21.3±1.7 岁)接受 MB 治疗。在正畸治疗开始前(t0)、治疗 3 个月后(t1)和 6 个月后(t2),评估菌斑指数(PI)、唾液流量、唾液缓冲能力以及 S. mutans 和乳杆菌的唾液水平。
CA 患者的 PI 始终保持在 0 级,而 MB 组的 PI 随时间呈统计学显著增加趋势。此外,在 t2 时,40 名 MB 参与者中的 37.5%(15 名参与者)显示变形链球菌(CFU/ml>105)的风险唾液水平(OR=7.40;95%CI=1.94-28.25;卡方=10.32;p=0.001)和乳杆菌(OR=23.40;95%CI=2.91-188.36;卡方=15.31;p=0.0001)。
比较所有数据,治疗 6 个月后,CA 组患者的唾液微生物定植水平低于 MB 组。考虑到正畸矫治器的类型,必须采取不同的额外菌斑控制和唾液微生物定植策略。